🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA March 2026 enforcement update — compounding pharmacies Page 16

FDA March 2026 enforcement update — compounding pharmacies

RegAffairsDC Fri, Dec 1, 2023 at 4:00 PM 275 replies 54,177 viewsPage 16 of 20
fiona_glasgow
Member
312
1,345
Aug 2024
Glasgow, UK
Dec 2, 2023 at 2:40 PM#76

Dr.PulmRoch — that is really helpful context on FDA March 2026. Follow-up question: did you experience any side effects during this phase?

I am in a similar situation (about to start) and trying to set realistic expectations.

46 23TrialTracker_MD, JennaRN, LabKate and 43 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Dec 2, 2023 at 2:57 PM#77

Want to share my personal experience related to FDA March 2026 enforcement since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 272 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 18 months later: I am down 87 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The FDA March 2026 aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

20 9KristenIndy, MarkLI_maint, Dr.PeteFamMed and 17 others
Reply Quote Save Share Report
fiona_VT
Member
178
890
Dec 2024
Vermont
Dec 2, 2023 at 3:14 PM#78

fiona_glasgow — that is really helpful context on FDA March 2026. Follow-up question: did you change anything about your diet at the same time?

I am in a similar situation (month 2) and trying to set realistic expectations.

Last edited: Dec 2, 2023 at 4:14 PM
29 1jason_sac26, chris_chi24, tampaLisa73 and 26 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Dec 2, 2023 at 3:31 PM#79

Want to share my personal experience related to FDA March 2026 enforcement since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 289 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 10 months later: I am down 39 lbs, my labs have normalized, and I am off 2 of my 3 medications. The FDA March 2026 aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

38 5JessicaM_2024, TomFromTexas, mike.trainer_LA and 35 others
Reply Quote Save Share Report
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Dec 2, 2023 at 3:48 PM#80

Just wanted to say — for anyone reading this FDA March 2026 thread who is feeling discouraged: it gets better. The first month are the hardest. Hang in there. 💪

45 7pete_manc_UK, anna.melb_AU, mark_tokyo and 42 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register